Calgidex Ag

Calgidex Ag is a technologically advanced wound dressing that incorporates the barrier effectiveness of ionic silver with the absorbency capabilities of calcium alginate and polyurethane foam. The patented matrix formulation forms a soft gel allowing the liberation of bioactive silver ions and providing a moist environment conducive to natural healing. Viridis manufactures this product under license from B. Braun Hospicare Ltd. Ireland, based on B. Braun’s Askina Calgitrol Ag product.

Calgidex Ag wound dressing is recommended for the management of infected or non-infected, partial to full thickness wounds, such as Stage I-IV pressure ulcers, venous ulcers and second-degree burns.

Calgidex Ag is also available as gel form in a polytube.

Hydrogel Sheets

Manufactured under license from the Board of Radiation & Isotope Technology, Bhabha Atomic Research Centre, India, Hydrogel sheets are used as dressings for the management of wounds including pressure ulcers, venous ulcers, dermal lesions, second-degree burns and donor sites. Based on moist wound healing, they provide comfort to patients through their cooling and soothing action.

Microfoam™ and Woundguard™

These innovative dressings, available as a polyurethene foam (Microfoam™) or a 12 ply cotton gauze (Woundguard™), prevent bacterial penetration and inhibits growth within wound dressings. They are based on the cutting edge, patented non-leaching antimicrobial NIMBUS® Technology from Quick-Med Technologies, USA, which TIME magazine called one of the ‘10 Best Discoveries of 2006’. NIMBUS® is based on non-toxic, long chain polymers with high charge density that provide superior efficacy via a physical action on microbes. By destroying bacteria at the cellular level, NIMBUS® eliminates the risk of developing drug resistance. The technology is highly effective against a multitude of bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE).